Wondfo Biotech

Wondfo Biotech (Stock Code: 300482) was established in 1992, with its headquarters located in Guangzhou Science City. It was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange on June 30, 2015. Wondfo Biotech focuses on the in vitro diagnostics sector under the medical device industry, specializing in the research and development, manufacturing, marketing, and service of rapid diagnostic reagents and supporting instruments for Point of Care Testing (POCT). As one of the leading enterprises in China's POCT industry, its products are sold in more than 140 countries and regions worldwide and are widely used in clinical testing, critical care, chronic disease management, primary healthcare, epidemic monitoring, disaster relief, on-site law enforcement, and personal health management at home.